文献速递呼吸衰竭与机械通气

一种新型储氧式低耗氧CPAP:Bag-CPAP

A new reservoir-based CPAP with low oxygen consumption: the Bag-CPAP.
PubMed 文献 · Crit Care · 2023-07-04
一句话结论体外实验中Bag-CPAP的FiO2/耗氧比最高但装置做功增加,临床观察20例急性呼吸衰竭患者耐受良好并显著改善呼吸困难。

该研究为台式-床旁研究,首先在台式实验中比较Bag-CPAP与四种CPAP装置及一台ICU呼吸机在PEEP 5–10 cm H2O、两个FiO2目标(40–60%与80–100%)下的FiO2与耗氧量,并评估装置做功;随后在法国两家医院对20例急性呼吸衰竭成人患者进行观察性临床研究,评估实际FiO2、PEEP、SpO2、呼吸频率与呼吸困难评分。台式实验中六种系统均达到40%最低FiO2目标,四种达到至少80% FiO2且PEEP维持在预设范围;无论FiO2目标如何,新型储氧式CPAP的FiO2/耗氧比最高,但Bag-CPAP的装置做功更高。临床研究中Bag-CPAP耐受良好,氧流量15 [15-16] L/min可达高FiO2(>90%),8 [7-9] L/min可达中等FiO2(>50%),引入Bag-CPAP后呼吸困难评分显著改善、SpO2升高。作者认为Bag-CPAP可能有助于在现场治疗急性呼吸衰竭患者,尤其面临氧供受限时。

要点

  • 台式实验中六种系统均达到40%最低FiO2目标,其中四种达到至少80% FiO2且PEEP维持在预设范围。
  • 无论FiO2目标为40–60%还是80–100%,新型储氧式CPAP的FiO2/耗氧比均为最高。
  • Bag-CPAP的装置做功高于其他装置。
  • 临床研究中Bag-CPAP耐受良好,氧流量15 [15-16] L/min可达高FiO2(>90%),8 [7-9] L/min可达中等FiO2(>50%)。
  • 引入Bag-CPAP后呼吸困难评分显著改善,SpO2升高。

适用人群与场景

  • 台式实验:Bag-CPAP、四种CPAP装置与一台ICU呼吸机。
  • 临床研究:法国两家医院20例急性呼吸衰竭成人患者。

诊断标准与关键阈值

  • 台式实验预设PEEP水平在5–10 cm H2O之间,FiO2目标为40–60%与80–100%。

研究设计与关键结果

  • 台式实验中六种系统均达到40%最低FiO2目标,四种达到至少80% FiO2且PEEP维持在预设范围。
  • 无论FiO2目标如何,新型储氧式CPAP的装置输送FiO2/耗氧比最高。
  • Bag-CPAP的装置做功高于其他装置。
  • 临床研究中Bag-CPAP耐受良好,氧流量15 [15-16] L/min可达高FiO2(>90%),8 [7-9] L/min可达中等FiO2(>50%)。
  • 引入Bag-CPAP后呼吸困难评分显著改善,SpO2升高。

证据类型、等级与局限

  • 证据类型:台式实验联合观察性临床研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为Bag-CPAP可能有助于在现场治疗急性呼吸衰竭患者,尤其面临氧供受限时。
  • Bag-CPAP装置做功较高,体外实验中FiO2/耗氧比最高。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Several noninvasive ventilatory supports rely in their design on high oxygen consumption which may precipitate oxygen shortage, as experienced during the COVID-19 pandemic. In this bench-to-bedside study, we assessed the performance of a new continuous positive airway pressure (CPAP) device integrating a large reservoir ("Bag-CPAP") designed to minimize oxygen consumption, and compared it with other CPAP devices.

METHODS: First, a bench study compared the performances of Bag-CPAP and four CPAP devices with an intensive care unit ventilator. Two FiO2 targets (40-60% and 80-100%) at a predefined positive end expiratory pressure (PEEP) level between 5 and 10 cm H2O were tested and fraction of inspired oxygen (FiO2) and oxygen consumption were measured. Device-imposed work of breathing (WOB) was also evaluated. Second, an observational clinical study evaluated the new CPAP in 20 adult patients with acute respiratory failure in two hospitals in France. Actual FiO2, PEEP, peripheral oxygen saturation, respiratory rate, and dyspnea score were assessed.

RESULTS: All six systems tested in the bench study reached the minimal FiO2 target of 40% and four reached at least 80% FiO2 while maintaining PEEP in the predefined range. Device-delivered FiO2/consumed oxygen ratio was the highest with the new reservoir-based CPAP irrespective of FiO2 target. WOB induced by the device was higher with Bag-CPAP. In the clinical study, Bag-CPAP was well tolerated and could reach high (> 90%) and moderate (> 50%) FiO2 with an oxygen flow rate of 15 [15-16] and 8 [7-9] L/min, respectively. Dyspnea score improved significantly after introduction of Bag-CPAP, and SpO2 increased.

CONCLUSIONS: In vitro, Bag-CPAP exhibited the highest oxygen saving properties albeit had increased WOB. It was well accepted clinically and reduced dyspnea. Bag-CPAP may be useful to treat patients with acute respiratory failure in the field, especially when facing constraints in oxygen delivery.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. de Beaufort E, Carteaux G, Morin F, et al. A new reservoir-based CPAP with low oxygen consumption: the Bag-CPAP. Crit Care. 2023. PMID: 37403149. doi:10.1186/s13054-023-04542-2

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。